| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 56.877 | 54.097 | 54.339 | 61.141 | 68.218 | 75.830 | 79.181 | 86.934 | 113.876 | 139.889 |
| Total Income - EUR | 56.945 | 54.164 | 54.405 | 61.488 | 69.617 | 79.716 | 85.159 | 86.997 | 114.661 | 139.890 |
| Total Expenses - EUR | 32.153 | 30.292 | 31.894 | 41.058 | 36.819 | 46.351 | 51.172 | 61.320 | 81.897 | 95.113 |
| Gross Profit/Loss - EUR | 24.792 | 23.872 | 22.511 | 20.430 | 32.798 | 33.365 | 33.988 | 25.677 | 32.764 | 44.778 |
| Net Profit/Loss - EUR | 23.084 | 23.324 | 21.967 | 19.815 | 32.102 | 32.855 | 33.238 | 24.929 | 31.743 | 40.581 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr Iordache Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 32.710 | 30.393 | 27.819 | 26.436 | 68.940 | 71.180 | 72.412 | 77.240 | 76.506 | 70.844 |
| Current Assets | 36.274 | 16.839 | 15.204 | 8.732 | 7.262 | 15.200 | 16.317 | 15.566 | 21.838 | 14.983 |
| Inventories | 20 | 0 | 0 | 0 | 0 | 0 | 58 | 7 | 0 | 0 |
| Receivables | 16.530 | 15.803 | 14.532 | 7.789 | 6.456 | 8.617 | 8.367 | 10.278 | 17.755 | 2.789 |
| Cash | 19.725 | 1.037 | 673 | 943 | 806 | 6.583 | 7.891 | 5.281 | 4.083 | 12.195 |
| Shareholders Funds | 65.890 | 43.228 | 39.218 | 30.702 | 40.715 | 72.798 | 82.165 | 84.232 | 95.221 | 78.369 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.138 | 4.067 | 3.901 | 4.504 | 35.837 | 13.816 | 6.962 | 8.943 | 3.394 | 7.459 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr Iordache Srl